The estimated Net Worth of David B Stevens is at least $2.23 Million dollars as of 6 December 2022. Mr. Stevens owns over 43,134 units of Veradigm Inc stock worth over $320,278 and over the last 8 years he sold MDRX stock worth over $1,594,482. In addition, he makes $311,500 as Independent Director at Veradigm Inc.
David has made over 2 trades of the Veradigm Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 43,134 units of MDRX stock worth $796,685 on 6 December 2022.
The largest trade he's ever made was selling 47,347 units of Veradigm Inc stock on 27 May 2022 worth over $797,797. On average, David trades about 9,048 units every 19 days since 2016. As of 6 December 2022 he still owns at least 32,384 units of Veradigm Inc stock.
You can see the complete history of Mr. Stevens stock trades at the bottom of the page.
David D. Stevens serves as Independent Director of the Company. He currently serves as a private advisor and investor in private equity in the healthcare services industry. From 1983 until 2006, Mr. Stevens served in various executive roles at Accredo Health Group, Inc. (formerly Accredo Health, Inc.) and its predecessor companies, serving as its Chief Executive Officer from 1995 until 2006, its Chairman of the Board from 1995 until 2005, and its President and Chief Operating Officer from 1993 until 1996. Accredo Health Group, Inc. was acquired by Medco Health Solutions, Inc. in 2005. Mr. Stevens currently serves as a director of Wright Medical Group, Inc., a publicly-traded orthopedic company that designs, manufactures, and distributes extremity and biologic solutions; and several privately-held healthcare companies. Mr. Stevens also has served as a director of Medco Health Solutions, Inc., a pharmacy benefits management company that was publicly-traded prior to its acquisition by Express Scripts, Inc. in 2012; Thomas & Betts Corporation, a manufacturer of electrical, electronic, mechanical, and utility products that was publicly-traded prior to its acquisition by ABB Ltd. in 2012; and Viasystems Group, Inc., a leading manufacturer of complex multi-layer printed circuit boards and electro-mechanical solutions that was publicly-traded prior to its acquisition by TTM Technologies, Inc. in 2015. Among other qualifications, Mr. Stevens brings extensive financial and operating expertise, leadership experience, experience with serving on boards of directors, and significant experience in the healthcare industry.
As the Independent Director of Veradigm Inc, the total compensation of David Stevens at Veradigm Inc is $311,500. There are 9 executives at Veradigm Inc getting paid more, with Paul Black having the highest compensation of $7,508,610.
David Stevens is 67, he's been the Independent Director of Veradigm Inc since 2012. There are no older and 17 younger executives at Veradigm Inc.
Over the last 21 years, insiders at Veradigm Inc have traded over $224,103,456 worth of Veradigm Inc stock and bought 10,933,033 units worth $72,033,281 . The most active insiders traders include Capital Management Llcstone..., Yancey L. Spruill, and Michael Kluger. On average, Veradigm Inc executives and independent directors trade stock every 28 days with the average trade being worth of $1,028,807. The most recent stock trade was executed by Capital Management Llcstone... on 28 February 2024, trading 10,222,875 units of MDRX stock currently worth $66,039,773.
allscripts (nasdaq: mdrx) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. our innovative solutions connect people, places and data across an open, connected community of health™. connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. to learn more, visit www.allscripts.com, twitter, youtube and blog.allscripts.com.
Veradigm Inc executives and other stock owners filed with the SEC include: